We identified 16 common mutations, 11 differentially methylated CpGs, and 25 copy number alterations of TMC genes in cancers, such as TMC5 amplification, were frequently detected in breast cancer (523/1062, 49.2% of patients). This evidence concerns the gene TMC5 and cancer.